Abbott reports fourth-quarter sales that miss analysts’ estimates.

Abbott shares fell after quarterly sales and early 2026 earnings guidance missed estimates, even as the company forecast ...

Morning Brief Host Julie Hyman tracks several of the day's top trending stock tickers, including GE Aerospace (GE) shares ...

ADJUSTED EARNINGS: Stripping out certain one-time items, earnings are forecast to come in at $1.50 a share. That compares with adjusted earnings of $1.34 a share a year earlier. REVENUE: Quarterly ...

Abbott Laboratories stock has reached a 52-week low, closing at $107.27. This marks a notable point for the healthcare company, as it navigates a challenging market environment. Over the past year, ...

Abbott Laboratories stock is emerging as a key way to play a potential rebound in healthcare, with analysts arguing that ...

Abbott's revenue has been flat over 15 months with steady Q3 EPS of $1.30, 7% growth, and upcoming Q4 international segment ...

Investing.com - Abbott Labs (NYSE: ABT) reported fourth quarter EPS of $1.50, in line with the analyst estimate of $1.50. Revenue for the quarter came in at $11.46B versus the consensus estimate of ...

Abbott Labs' nutrition business in Columbus reached a milestone in 2024, according to the company.